Business Context and Reporting Period
This Form 8-K Current Report was filed by Metavia Inc. (MTVA) on December 2, 2025. The filing discloses a material corporate action: the implementation of a reverse stock split to comply with The Nasdaq Capital Market's continued listing requirements. The Company is incorporated in Delaware and maintains its principal executive offices in Cambridge, Massachusetts.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on capital structure adjustments.
- Authorized Shares: Remains at 100 million.
- Outstanding Shares (Pre-Split): Approximately 25.4 million.
- Outstanding Shares (Post-Split): Approximately 2.3 million.
- Reverse Split Ratio: 1-for-11.
Material Changes Versus Prior Period
The primary material change is the reduction in the number of outstanding shares of Common Stock. On November 22, 2025, the Board of Directors approved a 1-for-11 reverse stock split, effective December 4, 2025. This action reduces the share count from approximately 25.4 million to 2.3 million. Additionally, the CUSIP number for the Common Stock will change to 64132R 503, while the trading symbol "MTVA" remains unchanged.
Guidance, Outlook, and Management Commentary
Management commentary is limited to the mechanics of the reverse stock split and its necessity for maintaining Nasdaq listing status. The filing notes that forward-looking statements are contained in the attached press release (Exhibit 99.1) but does not provide specific financial guidance or operational outlook in this document. The Company stated that the split is intended to enable compliance with Nasdaq requirements.
Key Mechanics:
- Effective Time: 5:00 p.m. Eastern Time on December 4, 2025.
- Trading Resumption: Expected to begin on a split-adjusted basis when Nasdaq opens on December 5, 2025.
- Fractional Shares: Will be rounded down to the next whole share; stockholders will receive cash for the fractional portion based on the closing sales price on the last trading day before the effective time.
- Adjustments: Proportionate adjustments will be made to the exercise price and number of shares for outstanding stock options, restricted stock units, and warrants.
Important Facts for Investor Verification
- Effective Date: Verify the exact timing of the split (December 4, 2025, at 5:00 p.m. ET) to ensure proper settlement of trades.
- Fractional Share Treatment: Confirm the cash payout mechanism for fractional shares, as these will be rounded down rather than rounded up.
- Derivative Adjustments: Review the specific adjustments to outstanding options, RSUs, and warrants to understand the impact on personal holdings.
- New CUSIP: Update trading systems to reflect the new CUSIP number (64132R 503) effective December 5, 2025.
- Registration Statements: Note that active S-3, S-1, and S-8 registration statements have been automatically amended to reflect the reduced share count.